2024 / 01

Next Paper
DOI: 10.47183/mes.2024.004

ORIGINAL RESEARCH

Correlations between serum levels of histamine, diamine oxidase, substance P in patients with chronic urticaria

Mikryukova NV1, Kalinina NM1,2
About authors

1 Nikiforov's All-Russian Center for Emergency and Radiation Medicine, EMERCOM of Russia, Saint Petersburg, Russia

2 Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia

Correspondence should be addressed: Natalya V. Mikryukova
Optikov, 54, Saint Petersburg, 197345, Russia; ofni.vokuyrkim@aylatan

About paper

Funding: the study was supported by the Nikiforov's All-Russian Center for Emergency and Radiation Medicine, EMERCOM of Russia, within the framework of the research project “Clinical and laboratory diagnosis of chronic urticaria in adults”.

Author contribution: the authors declare compliance of their authorship with the international ICMJE criteria. Mikryukova NV — data acquisition and analysis, manuscript writing; Kalinina NM — editing, introduction of fundamental changes, final approval of the version of the article.

Compliance with ethical standards: the subjects submitted the informed consent to participation in the study approved by the Ethics Committee of the Nikiforov's All-Russian Center for Emergency and Radiation Medicine, EMERCOM of Russia (protocol № 6/21 dated 24 June 2021).

Received: 2023-12-02 Accepted: 2024-02-16 Published online: 2024-03-14
|
  1. McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology. 2000; 22 (2): 108–24.
  2. Musazzi L, Tornese P, Sala N, Popoli M. What acute stress protocols can tell us about PTSD and stress-related neuropsychiatric disorders. Front Pharmacol. 2018; 12 (9): 758. DOI: 10.3389/fphar.2018.00758. PMID: 30050444.
  3. Malagelada JR. The brain-gut team. Dig Dis. 2020; 38 (4): 293–8. DOI: 10.1159/000505810. PMID: 32114574.
  4. Chen P, Zhang L, Feng Y, Liu YF, Si TL, Su Z, et al. Brain-gut axis and psychiatric disorders: A perspective from bibliometric and visual analysis. Front Immunol. 2022; 16 (13): 1047007. DOI: 10.3389/fimmu.2022.1047007. PMID: 36466907.
  5. Shapovalova NS. The role of the gut-brain axis in functional gastrointestinal disorders. Children's Medicine of the North-West. 2021; 9 (4): 33–50. Russian.
  6. Chen Y, Lyga J. Brain-skin connection: stress, inflammation and skin aging. Inflamm Allergy Drug Targets. 2014; 13 (3): 177–90. DOI: 10.2174/1871528113666140522104422. PMID: 24853682.
  7. Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015; 28: 203–9.
  8. Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, et al. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry. 2016; 21 (6): 797–805.
  9. Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018; 359 (6375): 592–7.
  10. Blagonravova AS, Galova EA, Shirokova IYu, Galova DA. The gut-brain axis — clinical study results. Experimental and Clinical Gastroenterology. 2023; 6: 5–13. DOI: 10.31146/1682-8658-ecg-214-6-5-13. Russian.
  11. Brsikyan LA, Poluektova EA, Poluektov MG. The gut microbiome as a factor in the development of Parkinson's disease. Neurology, Neuropsychiatry, Psychosomatics. 2023; 15 (1): 90–6. DOI: 10.14412/2074-2711-2023-1-90-96. Russian.
  12. Matsuno K, Ueta H, Shu Z, Xue-Dong X, Sawanobori Y, Kitazawa Y, et al. The microstructure of secondary lymphoid organs that support immune cell trafficking. Arch Histol Cytol. 2010; 73: 1–21. DOI: 10.1679/aohc.73.1.
  13. Thye AY, Bah YR, Law JW, Tan LT, He YW, Wong SH, et al. Gut-Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis. Biomedicines. 2022; 10 (5): 1037. DOI: 10.3390/biomedicines10051037. PMID: 35625774.
  14. Sinha S, Lin G, Ferenczi K. The skin microbiome and the gut-skin axis. Clin Dermatol. 2021; 39 (5): 829–39. DOI: 10.1016.
  15. Wang X, Li Y, Wu L, Xiao S, Ji Y, Tan Y, et al. Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression. Biomed Pharmacother. 2021; 137: 111065. DOI: 10.1016/j.biopha.2020.111065.
  16. Ferraretto A, Donetti E, García-Mena J, Pacheco-López G. Editorial: The gut-skin-brain axis in human health and disease. Front Nutr. 2023; 16 (10): 1155614. DOI: 10.3389/fnut.2023.1155614. PMID: 36875850.
  17. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocrine reviews. 2000; 21 (5): 457–87.
  18. Marek-Jozefowicz L, Czajkowski R, Borkowska A, Nedoszytko B, Żmijewski MA, Cubała WJ, et al. Axis in psoriasis-psychological, psychiatric, hormonal, and dermatological aspects. Int J Mol Sci. 2022; 23 (2): 669. DOI: 10.3390/ijms23020669. PMID: 35054853.
  19. Andrzej TS, Michal AZ, Przemyslaw MP, Jerzy PS, Ralf P, How UV. Light touches the brain and endocrine system through skin, and why, endocrinology. 2018; 159 (5): 1992–2007. DOI: 10.1210/en.2017-03230.
  20. Remröd C, Lonne-Rahm S, Nordlind K. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Arch Dermatol Res. 2007; 299 (2): 85–91. DOI: 10.1007/s00403-007-0745-x.
  21. Asadi S, Alysandratos KD, Angelidou A, Miniati A, Sismanopoulos N, Vasiadi M, et al. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol. 2012; 132 (2): 324–9. DOI: 10.1038/jid.2011.334.
  22. Mijouin L, Hillion M, Ramdani Y, Jaouen T, Duclairoir-Poc C, Follet-Gueye ML, et al. Effects of a skin neuropeptide (substance p) on cutaneous microflora. PLoS One. 2013; 8 (11): 78773.
  23. Danilicheva IV, Ilina NI, Luss LV, et al. Federal Clinical Recommendations. Urticaria. Russian Journal of Allergy. 2018; 15 (5): 47–62. Russian.
  24. Smolinska S, Jutel M, Crameri R, O’Mahony L. Histamine and gut mucosal immune regulation. Allergy. 2013; 69 (3): 273–81. DOI: 10.1111/all.12330.
  25. Yusuke H, Hiroshi N, Minoru M, Tsutomu C. Clinical significance of serum diamine oxidase activity in inflammatory bowel disease: Importance of evaluation of small intestinal permeability. Inflammatory Bowel Diseases. 2011; 17 (2): 23–5. DOI: 10.1002/ibd.21588.
  26. Xu Y, Yao R, Zhao W, et al. Spirocyclopiperazinium salt compound DXL-A-24 improves visceral sensation and gut microbiota in a rat model of irritable bowel syndrome. Heliyon. 2023; 9 (6): 16544. DOI: 10.1016/j.heliyon.2023.e16544.
  27. Raskov H, Burcharth J, Pommergaard HC, Rosenberg J.Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes. 2016; 7 (5): 365–83. DOI: 10.1080/19490976.2016.1218585.
  28. McEwen BS. The untapped power of allostasis promoted by healthy lifestyles. World Psychiatry. 2020; 19 (1): 57–8. DOI: 10.1002/wps.20720. PMID: 31922670.